{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:07:48Z","timestamp":1791259668712,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3174,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.bbmt.2006.04.008","type":"journal-article","created":{"date-parts":[[2006,7,24]],"date-time":"2006-07-24T09:10:12Z","timestamp":1153732212000},"page":"828-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":188,"title":["KIR Ligands and Prediction of Relapse after Unrelated Donor Hematopoietic Cell Transplantation for Hematologic Malignancy"],"prefix":"10.1016","volume":"12","author":[{"given":"Katharine C.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Malkki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Pinto-Agnello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Denis","family":"Bignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois","family":"Gratwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machteld","family":"Oudshoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Ringden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon J.","family":"van Rood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effie","family":"Petersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2006.04.008_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJM198009043031007","article-title":"Transplantation of marrow from an unrelated donor to a patient with acute leukemia","volume":"303","author":"Hansen","year":"1980","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2006.04.008_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-065X.1997.tb00979.x","article-title":"Hematopoietic stem cell transplants from unrelated donors","volume":"175","author":"Hansen","year":"1997","journal-title":"Immunol Rev."},{"key":"10.1016\/j.bbmt.2006.04.008_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM199303043280901","article-title":"Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program","volume":"328","author":"Kernan","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2006.04.008_bib4","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V97.6.1572","article-title":"Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia","volume":"97","author":"Cornelissen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1702519","article-title":"Unrelated donor marrow transplantation for acute myeloid leukemia","volume":"26","author":"Sierra","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2006.04.008_bib6","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood.V95.7.2219","article-title":"Unrelated donor marrow transplantation for chronic myelogenous leukemia","volume":"95","author":"McGlave","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib7","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2006.04.008_bib8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2003-01-0091","article-title":"Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors","volume":"102","author":"Giebel","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib9","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood-2004-04-1441","article-title":"Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias","volume":"105","author":"Beelen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood.V104.11.434.434","article-title":"The effect of killer immunoglobulin-like receptor (KIR) ligand incompatibility on outcome of unrelated donor bone marrow transplantation (UDT)","volume":"104","author":"Farag","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib11","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2002-04-1197","article-title":"Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor","volume":"100","author":"Davies","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.0001-2815.2004.00182.x","article-title":"The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD","volume":"63","author":"Bishara","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2006.04.008_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2141.2003.04604.x","article-title":"T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell depleted HLA-non-identical paediatric bone marrow transplantation","volume":"123","author":"Lowe","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbmt.2006.04.008_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-065X.2002.19004.x","article-title":"The killer cell immunoglobulin-like receptor (KIR) genomic region","volume":"190","author":"Hsu","year":"2002","journal-title":"Immunol Rev."},{"key":"10.1016\/j.bbmt.2006.04.008_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00251-002-0497-x","article-title":"Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression","volume":"54","author":"Yawata","year":"2002","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbmt.2006.04.008_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","article-title":"Human diversity in killer cell inhibitory receptor genes","volume":"7","author":"Uhrberg","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.bbmt.2006.04.008_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-7613(00)80393-3","article-title":"Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors","volume":"7","author":"Valiante","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.bbmt.2006.04.008_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1034\/j.1399-0039.2000.560403.x","article-title":"Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires","volume":"56","author":"Crum","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2006.04.008_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.gene.6363836","article-title":"Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations","volume":"3","author":"Norman","year":"2002","journal-title":"Genes Immun."},{"key":"10.1016\/j.bbmt.2006.04.008_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002510000281","article-title":"Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups","volume":"52","author":"Norman","year":"2001","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbmt.2006.04.008_bib21","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1097\/00007890-199912150-00024","article-title":"Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination","volume":"68","author":"Witt","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2006.04.008_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1034\/j.1399-0039.2001.057004358.x","article-title":"Genomic diversity of natural killer cell receptor genes in three populations","volume":"57","author":"Toneva","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2006.04.008_bib23","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.4049\/jimmunol.174.10.6540","article-title":"Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogenetic blood stem cell donors","volume":"174","author":"Leung","year":"2005","journal-title":"J Immunol."},{"key":"10.1016\/j.bbmt.2006.04.008_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0039.2005.00473.x","article-title":"Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion","volume":"66","author":"Denis","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2006.04.008_bib25","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.173.7.4273","article-title":"Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection\/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis","volume":"173","author":"Nelson","year":"2004","journal-title":"J Immunol."},{"key":"10.1016\/j.bbmt.2006.04.008_bib26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2006.04.008_bib27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1084\/jem.20041214","article-title":"Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success","volume":"200","author":"Hiby","year":"2004","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2006.04.008_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","article-title":"Determinants of antileukemia effects of allogeneic NK cells","volume":"172","author":"Leung","year":"2004","journal-title":"J Immunol."},{"key":"10.1016\/j.bbmt.2006.04.008_bib29","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in allogeneic hematopoietic stem cell transplantation in acute myelogenous leukemia (AML) predicted by donor KIR genotype and recipient HLA genotype in T-cell depleted HLA-identical sibling transplants","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ni1043","article-title":"Cis association of Ly49A with MHC class I restricts natural killer cell inhibition","volume":"5","author":"Doucey","year":"2004","journal-title":"Nat Immunol."},{"key":"10.1016\/j.bbmt.2006.04.008_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2006.04.008_bib32","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2004-08-3156","article-title":"A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules","volume":"105","author":"Fernandez","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib33","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1182\/blood-2003-02-0438","article-title":"The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia","volume":"103","author":"Cook","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2141.2005.05797.x","article-title":"Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C\u2013matched unrelated donor haematopoietic stem cell transplantation","volume":"131","author":"Giebel","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbmt.2006.04.008_bib35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0161-5890(02)00030-5","article-title":"A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors","volume":"38","author":"Boyington","year":"2001","journal-title":"Mol Immunol."},{"key":"10.1016\/j.bbmt.2006.04.008_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4049\/jimmunol.161.2.571","article-title":"Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition","volume":"161","author":"Winter","year":"1998","journal-title":"J Immunol."},{"key":"10.1016\/j.bbmt.2006.04.008_bib37","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood-2005-04-1644","article-title":"KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation","volume":"106","author":"Cooley","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.04.008_bib38","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/eji.1830271111","article-title":"Control of self-reactive cytotoxic T lymphocytes expressing \u03b3\u03b4 T cell receptors by natural killer inhibitory receptors","volume":"27","author":"Halary","year":"1997","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.bbmt.2006.04.008_bib39","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.bmt.1703043","article-title":"TCR \u03b3\u03b4 cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD185b) selectively lyse acute myeloid leukemia cells","volume":"27","author":"Dolstra","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2006.04.008_bib40","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/sj.leu.2403839","article-title":"A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation","volume":"19","author":"Verheyden","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.04.008_bib41","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood-2005-03-1039","article-title":"Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation","volume":"107","author":"Cook","year":"2006","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910600317X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910600317X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:26:22Z","timestamp":1761056782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387910600317X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S108387910600317X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.04.008","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KIR Ligands and Prediction of Relapse after Unrelated Donor Hematopoietic Cell Transplantation for Hematologic Malignancy","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}